The FDA issues a warning letter to Novo Nordisk over Ozempic and Wegovy concerns

The FDA has issued a warning letter to the maker of Ozimpic and WGOI. The agency says Nova Nordisk failed to report potential side effects in patients who took its blockbuster medications. The FDA cited three deaths among the patients, including one who died by suicide.The agency says the company did not report the deaths within the agency's required time frame, and that it also failed to investigate or report the suicide. In a statement, Nova Nordisk said it has been working diligently to address the FDA's ...